Article

Efficacy and Safety of Nadifloxacin and Benzoyl Peroxide versus Adapalene and Benzoyl Peroxide in Acne Vulgaris: A Randomized Open‑label Phase IV Clinical Trial

Arijit Ghosh1, Kapildev Das2★★ Corresponding author

  1. 1Departments of Pharmacology, College, Malda, West Bengal, India.
  2. 2Dermatology, Malda Medical College, Malda, West Bengal, India.

CORRESPONDENCE

Kapildev Das

Dermatology, Malda Medical College, Malda, West Bengal, India.

drarijitghosh@gmail.com

Received: 15-02-2018; Revised: 17-03-2018; Accepted: 05-06-2018.

Volume 9, Issue 1 · pp. 27–31 · PUBLISHED 2018 · DOI: 10.4103/jpp.JPP_20_18

View on JPP original site ↗

ABSTRACT

Objective: To compare the efficacy and safety of nadifloxacin and benzoyl peroxide versus adapalene and benzoyl peroxide in acne vulgaris. Materials and Methods: Patients fulfilling the inclusion criteria were divided into two groups. Patients in Group A received nadifloxacin and benzoyl peroxide. Patients in Group B received adapalene and benzoyl peroxide. Duration of treatment was 12 weeks. Changes in noninflammatory lesion count (NILC), inflammatory lesion count (ILC), total lesion count (TLC), investigator global assessment score (IGA) score, and Cardiff acne disability index (CADI) score was determined at weeks 0, 4, 8, and 12. Results: Combination of adapalene and benzoyl peroxide significantly decreased NILC, ILC, TLC, IGA score, and CADI score compared to the combination of nadifloxacin and benzoyl peroxide in acne vulgaris. Conclusion: Combination of adapalene and benzoyl peroxide is significantly more effective compared to the combination of nadifloxacin and benzoyl peroxide in the treatment of acne vulgaris.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Ghosh, A., & Das, K. (2018). Efficacy and Safety of Nadifloxacin and Benzoyl Peroxide versus Adapalene and Benzoyl Peroxide in Acne Vulgaris: A Randomized Open‑label Phase IV Clinical Trial. Journal of Pharmacology and Pharmacotherapeutics, 9(1), 27–31. https://doi.org/10.4103/jpp.JPP_20_18